InterCure
Manufacturing · New York, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
589 8th Ave Fl 6, New York City, New Yor...Phone Number
(646) 652-5800Website
www.intercure.comRevenue
$12.3 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
1
1
1
About InterCure
InterCure (dba Canndoc) (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) is the leading cannabis company outside of North America. Canndoc, a wholly owned subsidiary of InterCure, is Israel's largest licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products. InterCure leverages its market leading distribution network, best in class international partnerships and a high-margin vertically integrated "seed-to-sale" model to maintain its position as Israel's leading cannabis company as well as to drive further growth through global expansion.Explore more
InterCure Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is InterCure your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once InterCure has new funding data
Click to see if InterCure had a recent Job posting/layoffs
Earning: See what the market has to say on InterCure recently announced quarterly report
Product Launch: Get notified when InterCure launches new products
Congratulate Masked Content for being promoted to Masked Content at InterCure
Check if InterCure has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
InterCure, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if InterCure is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined InterCure as Masked Content
Find 2 more new buyers
Compare Similar Companies to InterCure
Compare insights from companies similar to InterCure, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
InterCure is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
InterCure is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about InterCure.
InterCure financials insights
Gather financial insights about InterCure, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Share Placement
$11M
InterCure Tech Stack
A closer look at the technologies used by InterCure
InterCure News & Media
Ehud Barak's cannabis company InterCure raises $11 million in private placement
Following the announcement, InterCure’s stock went up 7.76% by market close, WednesdayOrganigram and Canndoc Sign International Strategic Agreement
MONCTON, New Brunswick--(BUSINESS WIRE)---- $OGI--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, today announced that it has entered into a multi-year agreement for supply of dried flower to one of Israel’s largest and most established medical cannabis producers, Canndoc Ltd. (“Canndoc”), a subsidiary of InterCure Ltd. (TASE: INCR/INCR.TA). Canndoc has been a pioneer in pharmaceutiCellect Biotechnology Reports First Quarter 2020 Financial and Operating Results; Continues to Demonstrate Significant Progress Despite Adjusted Operations Due to COVID-19
TEL AVIV, Israel, May 21, 2020 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (NASDAQ: "APOP"), a developer of innovative technology which enables the functional selection of stem cells, today reported financial and operating results for the first quarter ended March 31, 2020 and provided an update on recent operating developments, including the status of the previously announced LOIs with Canndoc Ltd, a wholly owned subsidiary of publicly-traded Intercure Ltd. (TASE: INCR).Israeli medical cannabis firm InterCure plans Nasdaq listing: Reuters
Israel’s InterCure (INCR.TA), which recently entered the medical cannabis market, plans to list on Nasdaq by mid-2019, its controlling shareholder, Alex Rabinovitch, said on Thursday.
Read more news
Top Manufacturing Companies
See more top companies
Frequently Asked Questions Regarding InterCure
Sign Up For FreeTo access detailed company insights
InterCure (dba Canndoc) (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) is the leading cannabis company outside of North America. Canndoc, a wholly owned subsidiary of InterCure, is Israel's largest licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products. Int... Read More
